期刊
ORGANIC PROCESS RESEARCH & DEVELOPMENT
卷 26, 期 1, 页码 82-90出版社
AMER CHEMICAL SOC
DOI: 10.1021/acs.oprd.1c00071
关键词
antiviral agents; API; remdesivir; triazine; supply centered synthesis
资金
- Bill and Melinda Gates Foundation
This study presents a newly developed synthetic methodology for the production of Pyrrolo[2,1-f][1,2,4]triazine, an important starting material for the antiviral drug remdesivir. Through examining the mechanistic pathway, simple building blocks such as pyrrole, chloramine, and formamidine acetate were successfully utilized to obtain triazine 1 with an overall yield of 55% in a two-vessel-operated process. The research also focuses on the safety of the process, impurity profiles and control, and efforts towards scale-up for large-scale production.
Pyrrolo[2,1-f][1,2,4]triazine (1) is an important regulatory starting material in the production of the antiviral drug remdesivir. Compound 1 was produced through a newly developed synthetic methodology utilizing simple building blocks such as pyrrole, chloramine, and formamidine acetate by examining the mechanistic pathway for the process optimization exercise. Triazine 1 was obtained in 55% overall yield in a two-vessel-operated process. This work describes the safety of the process, impurity profiles and control, and efforts toward the scale-up of triazine for the preparation of kilogram quantity.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据